mdma
A recent study published in Science Advances investigated the effects of 3,4-Methylendioxymethamphetamine (MDMA), commonly known as ecstasy, on empathy in mice. The findings provide evidence that MDMA enhances empathy-like behaviors through the release of serotonin in the nucleus accumbens, a brain region associated with reward and social behaviors. The discovery provides valuable insights into the potential mechanisms by which MDMA could be used therapeutically for conditions such as post-traumatic stress disorder and autism spectrum disorder. “MDMA has been reported to promote prosocial beha...
PsyPost (UK)
A recent study published in the European Journal of Neuroscience provides new insights into how 3,4-methylenedioxymethamphetamine (MDMA), commonly known as ecstasy or molly, affects the brain’s processing of emotional stimuli. Researchers found that MDMA significantly altered the brain’s response to emotional faces, shedding light on the drug’s unique impact on social and emotional processing. MDMA is known for its recreational use due to its euphoric and empathogenic effects. It is also under investigation as a potential treatment for post-traumatic stress disorder (PTSD) when combined with p...
PsyPost (UK)
A recent case study published in Clinical Case Reports describes the journey of a 41-year-old woman who turned to psilocybin and MDMA to manage her debilitating post-COVID symptoms. The paper raises the intriguing possibility, which is far from certain, that psychedelic substances might help alleviate the psychological and cognitive symptoms associated with Long-COVID. Long-COVID, also known as post-acute sequelae of SARS-CoV-2 infection, encompasses a range of symptoms that persist well beyond the initial recovery from COVID-19. These symptoms can include fatigue, cognitive impairment, anxiet...
PsyPost (UK)
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら